23andMe Holding Co

Stocks

Genome sequencing specialist 23andMe increased quarterly revenue

The biotech company 23andMe Holding Co. (ME) reported revenue growth in the first quarter of the fiscal year 2023, which ended June…

Read More »
Back to top button